Pharma blister packaging refers to small packs formed from a form of thermoformed plastic film containing small quantity of medical product such as tablets, capsules or lozenges. Blister packaging provides important product protection and oxygen barrier. It ensures product safety, efficacy and consistency throughout the shelf life.
The global Pharma Blister Packaging Market is estimated to be valued at US$ 11.03 Bn or Mn in 2023 and is expected to exhibit a CAGR of 5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the pharma blister packaging market is development of sustainable and eco-friendly packaging solutions. Manufacturers are focusing on development of packaging made from renewable materials like paper, sugar cane fiber etc. to reduce dependency on plastic derived from fossil fuels. For instance, Amcor offers packaging made from Plantic which is a plant-based bio-polymer made from sugar. This reduces carbon footprint while providing effective protection to pharmaceutical products. With rising environmental concerns, demand for green blister packaging is expected to grow significantly over the forecast period.
SWOT Analysis
- Strength: Pharma blister packaging offers excellent protection from external damage, contamination and tampering for pharmaceutical products. It is one of the most effective ways to extend product shelf life.
- Weakness: Developing pharmaceutical products may require specialized equipment for blister packaging which requires significant capital investments. Frequent design changes also increase costs.
- Opportunity: Growth in generic drug market and expanding base of chronic diseases is driving demand for cost-effective blister packaging solutions. Increased preference for unit dose and child-resistant packaging also presents opportunities.
- Threats: Stringent regulatory compliance adds to production costs. Supply chain disruptions during pandemic affected raw material availability.
Key Takeaways
The global Pharma Blister Packaging Market is expected to witness high growth, exhibiting a CAGR of 5.0% over the forecast period, due to increasing preference for tamper-evident and child-resistant packaging among pharma manufacturers and regulators.
Regional analysis: North America dominated the market with over 30% market share in 2023 followed by Europe. Asia Pacific is expected to witness fastest growth during forecast period led by expanding pharmaceutical manufacturing industries in India and China along with rising generic drugs market.
Key players operating in the Pharma Blister Packaging market are Amcor Plc, Wonderpack group, Bilcare Limited, Sonoco Products Company, Honeywell International Inc., ACG Pharmapack Pvt. Ltd., West Rock Company, Constantia Flexibles GmbH, WINPAK LTD, Rohrer Corporation, Accupack, Nichrome Packaging Solutions, Nirmala Industries, etc.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.